|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM246208198 |
| 003 |
DE-627 |
| 005 |
20231224142549.0 |
| 007 |
tu |
| 008 |
231224s2014 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0820.xml
|
| 035 |
|
|
|a (DE-627)NLM246208198
|
| 035 |
|
|
|a (NLM)25678746
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Fry, Nicole L
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Oxidation-Induced Trapping of Drugs in Porous Silicon Microparticles
|
| 264 |
|
1 |
|c 2014
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 20.11.2019
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a An approach for the preparation of an oxidized porous silicon microparticle drug delivery system that can provide efficient trapping and sustained release of various drugs is reported. The method uses the contraction of porous silicon's mesopores, which occurs during oxidation of the silicon matrix, to increase the loading and retention of drugs within the particles. First, a porous Si (pSi) film is prepared by electrochemical etching of p-type silicon with a resistivity of >0.65 Ω cm in a 1:1 (v/v) HF/ethanol electrolyte solution. Under these conditions, the pore walls are sufficiently thin to allow for complete oxidation of the silicon skeleton under mild conditions. The pSi film is then soaked in an aqueous solution containing the drug (cobinamide or rhodamine B test molecules were used in this study) and sodium nitrite. Oxidation of the porous host by nitrite results in a shrinking of the pore openings, which physically traps the drug in the porous matrix. The film is subsequently fractured by ultrasonication into microparticles. Upon comparison with commonly used oxidizing agents for pSi such as water, peroxide, and dimethyl sulfoxide, nitrite is kinetically and thermodynamically sufficient to oxidize the pore walls of the pSi matrix, precluding reductive (by Si) or oxidative (by nitrite) degradation of the drug payload. The drug loading efficiency is significantly increased (by up to 10-fold), and the release rate is significantly prolonged (by 20-fold) relative to control samples in which the drug is loaded by infiltration of pSi particles postoxidation. We find that it is important that the silicon skeleton be completely oxidized to ensure the drug is not reduced or degraded by contact with elemental silicon during the particle dissolution-drug release phase
|
| 650 |
|
4 |
|a Journal Article
|
| 700 |
1 |
|
|a Boss, Gerry R
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sailor, Michael J
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Chemistry of materials : a publication of the American Chemical Society
|d 1998
|g 26(2014), 8 vom: 22. Apr., Seite 2758-2764
|w (DE-627)NLM098194763
|x 0897-4756
|7 nnns
|
| 773 |
1 |
8 |
|g volume:26
|g year:2014
|g number:8
|g day:22
|g month:04
|g pages:2758-2764
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 26
|j 2014
|e 8
|b 22
|c 04
|h 2758-2764
|